ANI Pharmaceuticals Inc
ANIPHealthcare|Drug Manufacturers - Specialty & Generic|USA
$82.07
-1.68 (-2.01%)
DCF (FCF)
$45.65
Tangible Book
$1.43
Graham Number
$13.56
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (197)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| CAREY STEPHEN P. | SVP & CFO | 2026-07-02 | SELL | 3,313 | $86 | $284.9K |
| CAREY STEPHEN P. | SVP & CFO | 2026-06-29 | SELL | 2,850 | $84.12 | $239.7K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2026-06-12 | SELL | 500 | $82.03 | $41K |
| HAUGHEY THOMAS | Director | 2026-06-08 | SELL | 2,000 | $80.88 | $161.8K |
| CAREY STEPHEN P. | SVP & CFO | 2026-06-05 | SELL | 3,312 | $80 | $265K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2026-05-13 | SELL | 500 | $78.16 | $39.1K |
| Walsh Patrick D | Director | 2026-05-13 | SELL | 13,973 | $80.66 | $1127.1K |
| Gutwerg Ori | SVP, GENERICS | 2026-05-12 | SELL | 2,772 | $79.5 | $220.4K |
| Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | 2026-05-12 | SELL | 459 | $79.21 | $36.4K |
| Lalwani Nikhil | PRESIDENT & CEO | 2026-05-11 | SELL | 55,000 | $77.57 | $4266.4K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2026-04-13 | SELL | 500 | $77.95 | $39K |
| Mutz Christopher | HEAD OF RARE DISEASE | 2026-03-13 | SELL | 3,162 | $71.64 | $226.5K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2026-03-13 | SELL | 500 | $72.62 | $36.3K |
| Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | 2026-03-11 | SELL | 4,772 | $74.91 | $357.5K |
| Mutz Christopher | HEAD OF RARE DISEASE | 2026-03-09 | SELL | 5,723 | $74.19 | $424.6K |
| Davis Krista | SVP, CHIEF HR OFFICER | 2026-03-09 | SELL | 6,572 | $74.33 | $488.5K |
| CAREY STEPHEN P. | SVP & CFO | 2026-03-05 | SELL | 7,312 | $75.5 | $552.1K |
| Walsh Patrick D | Director | 2026-03-03 | SELL | 6,000 | $74.23 | $445.4K |
| Gutwerg Ori | SVP, GENERICS | 2026-03-03 | SELL | 2,060 | $76.5 | $157.6K |
| Mutz Christopher | HEAD OF RARE DISEASE | 2026-03-02 | SELL | 417 | $74 | $30.9K |
| Mutz Christopher | HEAD OF RARE DISEASE | 2026-02-20 | SELL | 5,323 | $78.02 | $415.3K |
| Davis Krista | SVP, CHIEF HR OFFICER | 2026-02-20 | SELL | 3,814 | $77.74 | $296.5K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2026-02-13 | SELL | 500 | $76.8 | $38.4K |
| Mutz Christopher | HEAD OF RARE DISEASE | 2026-02-12 | SELL | 7,032 | $76.55 | $538.3K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2026-01-13 | SELL | 500 | $84.33 | $42.2K |
| Davis Krista | SVP, CHIEF HR OFFICER | 2025-12-18 | SELL | 1,622 | $82.4 | $133.7K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2025-12-12 | SELL | 400 | $82.32 | $32.9K |
| TANNENBAUM RENEE P | Director | 2025-12-05 | SELL | 1,800 | $81.15 | $146.1K |
| Walsh Patrick D | Director | 2025-11-13 | SELL | 8,643 | $86.88 | $750.9K |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2025-11-13 | SELL | 14,736 | $89.06 | $1312.4K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2025-11-13 | SELL | 400 | $87.27 | $34.9K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2025-10-13 | SELL | 400 | $90.09 | $36K |
| Davis Krista | SVP, CHIEF HR OFFICER | 2025-09-19 | SELL | 1,000 | $98.04 | $98K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2025-09-12 | SELL | 400 | $98.42 | $39.4K |
| Pera Antonio R | Director | 2025-09-03 | SELL | 7,292 | $94.94 | $692.3K |
| Leonard Matthew J | Director | 2025-08-25 | SELL | 2,528 | $90.62 | $229.1K |
| Davis Krista | SVP, CHIEF HR OFFICER | 2025-08-22 | SELL | 1,763 | $91.1 | $160.6K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2025-08-21 | SELL | 100,000 | $90.36 | $9036K |
| Pera Antonio R | Director | 2025-08-20 | SELL | 5,421 | $89.73 | $486.4K |
| Leonard Matthew J | Director | 2025-08-18 | SELL | 6,937 | $88.17 | $611.6K |
| Thoma Jeanne | Director | 2025-08-18 | SELL | 21,540 | $89.15 | $1920.3K |
| Walsh Patrick D | Director | 2025-08-15 | SELL | 9,000 | $89.05 | $801.5K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2025-08-15 | SELL | 100,000 | $88.25 | $8825K |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2025-08-15 | SELL | 20,000 | $86.97 | $1739.4K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2025-08-13 | SELL | 400 | $88.87 | $35.5K |
| Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | 2025-08-12 | SELL | 4,975 | $85.71 | $426.4K |
| Lalwani Nikhil | PRESIDENT & CEO | 2025-08-12 | SELL | 56,960 | $85.93 | $4894.6K |
| Gutwerg Ori | SVP, GENERICS | 2025-08-12 | SELL | 5,873 | $86.53 | $508.2K |
| CAREY STEPHEN P. | SVP & CFO | 2025-08-12 | SELL | 50,000 | $86.07 | $4303.5K |
| HAUGHEY THOMAS | Director | 2025-08-12 | SELL | 19,341 | $85.93 | $1662K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2025-07-14 | SELL | 400 | $64.88 | $26K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2025-06-13 | SELL | 400 | $61.37 | $24.5K |
| Gutwerg Ori | SVP, GENERICS | 2025-05-15 | SELL | 881 | $60.07 | $52.9K |
| Mutz Christopher | HEAD OF RARE DISEASE | 2025-05-14 | SELL | 4,000 | $60.45 | $241.8K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2025-05-13 | SELL | 400 | $62.2 | $24.9K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2025-05-09 | SELL | 700 | $76.83 | $53.8K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2025-04-14 | SELL | 400 | $68.96 | $27.6K |
| Davis Krista | SVP, CHIEF HR OFFICER | 2025-03-19 | SELL | 1,866 | $65 | $121.3K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2025-03-13 | SELL | 400 | $63.33 | $25.3K |
| Davis Krista | SVP, CHIEF HR OFFICER | 2025-03-07 | SELL | 1,000 | $60.86 | $60.9K |
| Gutwerg Ori | SVP, GENERICS | 2025-03-05 | SELL | 5,384 | $60 | $323K |
| Davis Krista | SVP, CHIEF HR OFFICER | 2025-02-21 | SELL | 1,000 | $60.2 | $60.2K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2025-02-13 | SELL | 400 | $59.54 | $23.8K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2025-01-13 | SELL | 400 | $53.92 | $21.6K |
| CAREY STEPHEN P. | SVP & CFO | 2024-12-17 | SELL | 7,500 | $55.79 | $418.4K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2024-12-13 | SELL | 250 | $56.24 | $14.1K |
| Davis Krista | SVP, CHIEF HR OFFICER | 2024-12-11 | SELL | 1,000 | $60 | $60K |
| Lalwani Nikhil | PRESIDENT & CEO | 2024-11-26 | SELL | 33,481 | $57.99 | $1941.6K |
| Mutz Christopher | HEAD OF RARE DISEASE | 2024-11-15 | SELL | 6,500 | $57.7 | $375.1K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2024-11-13 | SELL | 250 | $61.36 | $15.3K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2024-10-14 | SELL | 250 | $57.19 | $14.3K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2024-09-13 | SELL | 250 | $56.82 | $14.2K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2024-08-13 | SELL | 250 | $59.62 | $14.9K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-07-18 | SELL | 2,743 | $62 | $170.1K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-07-17 | SELL | 47,257 | $63.73 | $3011.7K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2024-07-12 | SELL | 250 | $64.91 | $16.2K |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2024-07-01 | SELL | 20,000 | $63.44 | $1268.8K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-06-21 | SELL | 20,000 | $58.9 | $1178K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-06-20 | SELL | 30,000 | $60.59 | $1817.7K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2024-06-13 | SELL | 250 | $63.8 | $16K |
| Gutwerg Ori | SVP, GENERICS | 2024-06-05 | SELL | 2,985 | $67 | $200K |
| CAREY STEPHEN P. | SVP & CFO | 2024-06-04 | SELL | 5,000 | $63.58 | $317.9K |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2024-06-03 | SELL | 20,000 | $64.41 | $1288.2K |
| Mutz Christopher | HEAD OF RARE DISEASE | 2024-05-21 | SELL | 2,000 | $61.61 | $123.2K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-05-20 | SELL | 12,855 | $61.81 | $794.6K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-05-17 | SELL | 37,145 | $64.37 | $2391K |
| TANNENBAUM RENEE P | Director | 2024-05-16 | SELL | 2,000 | $63.87 | $127.7K |
| Lalwani Nikhil | PRESIDENT & CEO | 2024-05-14 | SELL | 16,669 | $66.1 | $1101.8K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2024-05-13 | SELL | 250 | $67.69 | $16.9K |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2024-05-01 | SELL | 20,000 | $66.62 | $1332.4K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-04-19 | SELL | 27,232 | $65.1 | $1772.8K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-04-17 | SELL | 22,768 | $65.91 | $1500.6K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2024-04-12 | SELL | 250 | $67.79 | $16.9K |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2024-04-01 | SELL | 20,000 | $67.25 | $1345K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2024-03-13 | SELL | 250 | $66.54 | $16.6K |
| CAREY STEPHEN P. | SVP & CFO | 2024-03-11 | SELL | 7,787 | $65.55 | $510.4K |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2024-03-11 | SELL | 20,000 | $65.81 | $1316.2K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-03-08 | SELL | 10,000 | $67.17 | $671.7K |
| Lalwani Nikhil | PRESIDENT & CEO | 2024-03-08 | SELL | 45,257 | $66.1 | $2991.5K |
| Marken James G. | SVP OPS & PROD DEV | 2024-03-07 | SELL | 24,338 | $66.37 | $1615.3K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-03-07 | SELL | 40,000 | $65.77 | $2630.8K |
| Mutz Christopher | HEAD OF RARE DISEASE | 2024-03-05 | SELL | 5,000 | $66 | $330K |
| Pera Antonio R | Director | 2024-03-04 | SELL | 7,000 | $65.2 | $456.4K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2024-02-13 | SELL | 250 | $56.04 | $14K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-01-23 | SELL | 25,216 | $56.17 | $1416.4K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2024-01-18 | SELL | 24,784 | $55.29 | $1370.3K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2024-01-12 | SELL | 250 | $56.43 | $14.1K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-12-19 | SELL | 50,000 | $52.55 | $2627.5K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2023-12-11 | SELL | 250 | $49.21 | $12.3K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-11-17 | SELL | 13,000 | $51 | $663K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-11-16 | SELL | 37,000 | $53 | $1961K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-11-16 | SELL | 36,190 | $53 | $1918.1K |
| Davis Krista | SVP, CHIEF HR OFFICER | 2023-11-15 | SELL | 2,622 | $53.81 | $141.1K |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | 2023-11-13 | SELL | 250 | $52.03 | $13K |
| Mutz Christopher | HEAD OF RARE DISEASE | 2023-11-10 | SELL | 3,000 | $52.47 | $157.4K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-10-19 | SELL | 25,000 | $57.75 | $1443.8K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-10-16 | SELL | 25,000 | $57.96 | $1449K |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2023-10-02 | SELL | 20,000 | $56.48 | $1129.6K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-09-19 | SELL | 50,000 | $61.81 | $3090.5K |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2023-09-01 | SELL | 20,000 | $64.7 | $1294K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-08-29 | SELL | 50,000 | $63.22 | $3161K |
| Gutwerg Ori | SVP, GENERICS | 2023-08-23 | SELL | 15,561 | $62.39 | $970.9K |
| Marken James G. | SVP OPS & PROD DEV | 2023-08-23 | SELL | 3,932 | $63 | $247.7K |
| MERIDIAN VENTURE PARTNERS II LP | 10% Owner | 2023-08-16 | SELL | 200,000 | $58.5 | $11700K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-08-15 | SELL | 50,000 | $61.35 | $3067.5K |
| Lalwani Nikhil | PRESIDENT & CEO | 2023-08-15 | SELL | 68,282 | $58.32 | $3982.2K |
| CAREY STEPHEN P. | SVP & CFO | 2023-08-14 | SELL | 17,639 | $61.37 | $1082.5K |
| Pera Antonio R | Director | 2023-08-14 | SELL | 3,000 | $60.37 | $181.1K |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2023-08-01 | SELL | 20,000 | $51.06 | $1021.2K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-07-21 | SELL | 23,469 | $52.02 | $1220.9K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-07-18 | SELL | 26,531 | $51.02 | $1353.6K |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2023-07-03 | SELL | 20,000 | $53.43 | $1068.6K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-06-23 | SELL | 50,000 | $51.7 | $2585K |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2023-06-22 | SELL | 20,000 | $51.32 | $1026.4K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2023-06-22 | SELL | 40,000 | $51.75 | $2070K |
| MERIDIAN VENTURE PARTNERS II LP | 10% Owner | 2022-12-01 | SELL | 200,000 | $38.5 | $7700K |
| Marken James G. | SVP OPS & PROD DEV | 2022-08-15 | SELL | 18,066 | $37.26 | $673.1K |
| Lalwani Nikhil | PRESIDENT & CEO | 2022-03-21 | BUY | 7,224 | $27.69 | $200K |
| Walsh Patrick D | Director | 2022-03-21 | BUY | 5,000 | $27.76 | $138.8K |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | 2022-03-21 | BUY | 10,000 | $27.51 | $275.1K |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | 2022-03-17 | BUY | 10,000 | $27.65 | $276.5K |
| Thoma Jeanne | Director | 2021-12-20 | BUY | 1,072 | $46.47 | $49.8K |
| Pera Antonio R | Director | 2021-12-07 | BUY | 3,000 | $42.26 | $126.8K |
| HAUGHEY THOMAS | Director | 2021-12-06 | BUY | 2,500 | $39.38 | $98.5K |
| Walsh Patrick D | Director | 2021-03-15 | BUY | 4,000 | $32.89 | $131.6K |
| Walsh Patrick D | Director | 2020-11-09 | BUY | 5,000 | $25.96 | $129.8K |
| Walsh Patrick D | CHAIRMAN, INTERIM PRES. & CEO | 2020-08-10 | BUY | 10,000 | $30.78 | $307.8K |
| HAUGHEY THOMAS | Director | 2020-03-04 | BUY | 5,000 | $45.1 | $225.5K |
| MERIDIAN VENTURE PARTNERS II L | 10% Owner | 2019-08-20 | SELL | 7,579 | $68.21 | $517K |
| MERIDIAN VENTURE PARTNERS II L | 10% Owner | 2019-08-20 | SELL | 7,579 | $68.21 | $517K |
| MERIDIAN VENTURE PARTNERS II L | 10% Owner | 2019-08-16 | SELL | 62,024 | $69.04 | $4282.1K |
| MERIDIAN VENTURE PARTNERS II L | 10% Owner | 2019-08-13 | SELL | 61,697 | $71.64 | $4420K |
| NASH DAVID | Director | 2019-05-24 | BUY | 1,445 | $68.76 | $99.4K |
| Marken James G. | SVP Ops & Prod Dev | 2019-05-17 | SELL | 8,907 | $70.67 | $629.5K |
| PRZYBYL ARTHUR | President and CEO | 2019-05-15 | SELL | 30,000 | $70.07 | $2102.1K |
| HAUGHEY THOMAS | Director | 2019-05-15 | BUY | 2,500 | $69.3 | $173.3K |
| Marken James G. | SVP Ops & Prod Dev | 2019-05-14 | SELL | 4,917 | $70.31 | $345.7K |
| Schrepfer Robert W | SVP - New Bus Dev & Spec Sales | 2019-05-13 | SELL | 2,409 | $71.13 | $171.4K |
| PRZYBYL ARTHUR | President and CEO | 2019-03-19 | SELL | 27,625 | $63.53 | $1755K |
| Schrepfer Robert W | SVP - New Bus Dev & Spec Sales | 2019-03-13 | SELL | 11,796 | $64.44 | $760.1K |
| MARSHBANKS TRACY | Director | 2018-05-16 | SELL | 38,236 | $62.33 | $2383.2K |
| MARSHBANKS TRACY | Director | 2018-05-10 | SELL | 62,431 | $62.07 | $3875.1K |
| MARSHBANKS TRACY | Director | 2018-04-18 | SELL | 33,200 | $62.09 | $2061.4K |
| RAYNOR DANIEL | Director | 2018-03-19 | SELL | 7,215 | $60.85 | $439K |
| MARSHBANKS TRACY | Director | 2018-03-14 | SELL | 1,912 | $63.1 | $120.6K |
| RAYNOR DANIEL | Director | 2018-03-14 | SELL | 27,964 | $62.24 | $1740.5K |
| PRZYBYL ARTHUR | President and CEO | 2018-03-14 | SELL | 40,000 | $61.83 | $2473.2K |
| MARSHBANKS TRACY | Director | 2018-03-12 | SELL | 64,221 | $63.03 | $4047.8K |
| Marken James G. | SVP Ops & Prod Dev | 2018-03-05 | SELL | 4,177 | $61.92 | $258.6K |
| Schrepfer Robert W | SVP - New Bus Dev & Spec Sales | 2018-03-01 | SELL | 28,652 | $61.66 | $1766.7K |
| PRZYBYL ARTHUR | President and CEO | 2018-03-01 | SELL | 23,986 | $61.23 | $1468.7K |
| PRZYBYL ARTHUR | President and CEO | 2016-08-22 | SELL | 37,455 | $66.97 | $2508.4K |
| Schrepfer Robert W | VP Bus Dev & Con Mfg | 2016-08-08 | SELL | 12,500 | $67.06 | $838.3K |
| Marken James G. | Vice President, Operations | 2015-12-18 | SELL | 3,500 | $43.26 | $151.4K |
| PRZYBYL ARTHUR | President and CEO | 2015-11-12 | BUY | 2,500 | $40.95 | $102.4K |
| Marken James G. | Vice President, Operations | 2015-03-19 | SELL | 15,000 | $66.5 | $997.5K |
| Arnold Charlotte C. | Vice President and CFO | 2015-03-12 | SELL | 45,000 | $63 | $2835K |
| PRZYBYL ARTHUR | President and CEO | 2015-03-12 | SELL | 75,000 | $63 | $4725K |
| MERIDIAN VENTURE PARTNERS II L | 10% Owner | 2015-03-12 | SELL | 300,000 | $63 | $18900K |
| RAYNOR DANIEL | Director | 2015-03-12 | SELL | 200,000 | $63 | $12600K |
| MARSHBANKS TRACY | Director | 2015-03-12 | SELL | 210,000 | $63 | $13230K |
| MANGANO ROSS J | Director | 2014-09-15 | BUY | 3,000 | $27.49 | $82.5K |
| PRZYBYL ARTHUR | President and CEO | 2014-09-09 | BUY | 1,000 | $26.5 | $26.5K |
| Marken James G. | Vice President, Operations | 2014-06-18 | SELL | 5,000 | $34.28 | $171.4K |
| MARSHBANKS TRACY | Director | 2014-05-08 | SELL | 1,381 | $30.02 | $41.5K |
| MANGANO ROSS J | Director | 2014-05-07 | BUY | 2,000 | $30.38 | $60.8K |
| MARSHBANKS TRACY | Director | 2014-03-21 | SELL | 21,767 | $31.42 | $683.9K |
| MERIDIAN VENTURE PARTNERS II L | 10% Owner | 2014-03-20 | SELL | 20,922 | $32.12 | $672K |
| MARSHBANKS TRACY | Director | 2014-03-19 | SELL | 25,358 | $33.68 | $854.1K |
| MERIDIAN VENTURE PARTNERS II L | 10% Owner | 2014-03-18 | SELL | 60,540 | $34.07 | $2062.6K |
| RAYNOR DANIEL | Director | 2014-03-14 | SELL | 12,347 | $33.85 | $417.9K |
| MERIDIAN VENTURE PARTNERS II L | 10% Owner | 2014-03-13 | SELL | 87,723 | $32.48 | $2849.2K |
| MERIDIAN VENTURE PARTNERS II L | 10% Owner | 2014-03-13 | SELL | 87,723 | $32.48 | $2849.2K |
| RAYNOR DANIEL | Director | 2014-03-12 | SELL | 21,111 | $33.89 | $715.5K |
| RAYNOR DANIEL | Director | 2014-03-12 | SELL | 21,111 | $33.89 | $715.5K |
| MANGANO ROSS J | Director | 2013-11-07 | BUY | 9,000 | $11.27 | $101.4K |
| MANGANO ROSS J | Director | 2013-08-20 | BUY | 10,000 | $7.47 | $74.7K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked